BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33890484)

  • 21. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
    Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARID1A mutations in cancer: another epigenetic tumor suppressor?
    Wu JN; Roberts CW
    Cancer Discov; 2013 Jan; 3(1):35-43. PubMed ID: 23208470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
    Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
    Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
    Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
    Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
    Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
    Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
    J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.
    Luo Q; Wu X; Chang W; Zhao P; Zhu X; Chen H; Nan Y; Luo A; Zhou X; Su D; Jiao W; Liu Z
    Cancer Res; 2020 Feb; 80(3):406-417. PubMed ID: 32015157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.
    Wang X; Nagl NG; Wilsker D; Van Scoy M; Pacchione S; Yaciuk P; Dallas PB; Moran E
    Biochem J; 2004 Oct; 383(Pt 2):319-25. PubMed ID: 15170388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
    Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
    Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes.
    Mohrmann L; Langenberg K; Krijgsveld J; Kal AJ; Heck AJ; Verrijzer CP
    Mol Cell Biol; 2004 Apr; 24(8):3077-88. PubMed ID: 15060132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
    Shain AH; Pollack JR
    PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation.
    Singh AP; Archer TK
    Nucleic Acids Res; 2014 Mar; 42(5):2958-75. PubMed ID: 24335282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.
    Sun D; Tian L; Zhu Y; Wo Y; Liu Q; Liu S; Li H; Hou H
    Mol Med; 2020 Aug; 26(1):78. PubMed ID: 32791957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer.
    Wu JI
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):54-69. PubMed ID: 22194014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
    Coatham M; Li X; Karnezis AN; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Blake Gilks C; Huntsman DG; Stewart CJ; Postovit LM; Köbel M; Lee CH
    Mod Pathol; 2016 Dec; 29(12):1586-1593. PubMed ID: 27562491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the BAF complex in advanced prostate cancer.
    Hartley A; Leung HY; Ahmad I
    Expert Opin Drug Discov; 2021 Feb; 16(2):173-181. PubMed ID: 32936685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.